International Journal of Molecular Sciences (Mar 2020)

Intramuscular Injection of Combined Calf Blood Compound (CFC) and Homeopathic Drug Tr14 Accelerates Muscle Regeneration In Vivo

  • Patrick Belikan,
  • Lisa Nauth,
  • Lars-Christopher Färber,
  • Frédéric Abel,
  • Eva Langendorf,
  • Philipp Drees,
  • Pol Maria Rommens,
  • Ulrike Ritz,
  • Stefan G. Mattyasovszky

DOI
https://doi.org/10.3390/ijms21062112
Journal volume & issue
Vol. 21, no. 6
p. 2112

Abstract

Read online

Skeletal muscle injuries in competitive sports cause lengthy absences of athletes from tournaments. This is of tremendous competitive and economic relevance for both the athletes and their respective clubs. Therapy for structural muscle lesions aims to promote regeneration and fast-track return-to-play. A common clinical treatment strategy for muscle injuries is the intramuscular injection of calf blood compound and the homeopathic drug, Tr14. Although the combination of these two agents was reported to reduce recovery time, the regulatory mechanism whereby this occurs remains unknown. In this in vivo study, we selected a rat model of mechanical muscle injury to investigate the effect of this combination therapy on muscle regeneration. Gene expression analysis and histological images revealed that this combined intramuscular injection for muscle lesions can enhance the expression of pro-myogenic genes and proteins and accelerate muscle regeneration. These findings are novel and depict the positive effects of calf blood compound and the homeopathic drug, Tr14, which are utilized in the field of Sports medicine.

Keywords